Amneal Pharmaceuticals
Amneal Pharmaceuticals Inc is a pharmaceutical manufacturing enterprise headquartered in Bridgewater, New Jersey. The company develops, manufactures, and commercializes a broad portfolio of generic pharmaceuticals, specialty branded medicines, and complex injectable therapeutics. Its product lineup supports diverse clinical categories including neurology, endocrinology, infectious disease, and critical care. Principal revenue is derived through wholesale sales of pharmaceutical products to retail pharmacy chains, pharmaceutical distributors, and institutional healthcare providers. The enterprise operates advanced manufacturing and research facilities. Amneal Pharmaceuticals Inc is publicly listed on the Nasdaq Stock Market.
6 of the funds FundTelligence covers report a position in Amneal Pharmaceuticals.
- Legal name
- Amneal Pharmaceuticals Inc
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 6
Funds holding Amneal Pharmaceuticals
- BlackRock iShares NASDAQ US Biotechnology UCITS ETF — BlackRock · 0.45 % (full portfolio disclosed, October 2026)
- Mercer Global High Yield Bond Fund — Mercer · 0.16 % (full portfolio disclosed, December 2025)
- T. Rowe Price Global High Yield Bond Fund — T. Rowe Price · 0.11 % (full portfolio disclosed, September 2026)
- DNB Global Enhanced Small Cap — DNB · 0.04 % (full portfolio disclosed, September 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.04 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.02 % (partially disclosed portfolio, June 2026)